A common sexual side effect men face after prostate cancer surgery is erectile dysfunction (the inability to achieve or sustain an erection suitable for sexual intercourse often caused by medications, chronic illnesses or poor blood flow to the penis). I...

My research staff and I at Fox Chase Cancer Center have recently launched a new study called PROGRESS (Prostate Cancer Online Guide& Resources for Electronic Survivorship Service) for men who have completed prostate cancer treatment within the last year...

Prostate cancer is the second leading cause of cancer death in men in the United States. The Federal Drug Administration (FDA) approved a type of blood test, prostate specific antigen (PSA), in 1986. Since then, PSA has been widely used for prostate canc...

In a recent article in the Journal of the American Medical Association, entitled, “Overdiagnosis and Overtreatment in Cancer An Opportunity for Improvement,” a group of experts discussed the findings from a National Cancer Institute working group designed t...

The management of clinically localized prostate cancer, or cancer that has not spread beyond the prostate gland, is complex. There are a number of treatment options, ranging from close observation with frequent reassessment (active surveillance), surgery, a...

Bone mineral density (DEXA) screening among men with prostate cancer: a missed opportunity Prostate cancer is the most common cancer among men in the United States and the second leading cause of cancer death.  The use of androgen-deprivation therap...